name: Complex extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device with primary posterior capsulorrhexis, by internal approach


name: Complex extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device with suture support for intraocular lens, by internal approach


name: Complex extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device, by internal approach, in patient in amblyogenic developmental stage


name: Complex manual extracapsular cataract removal with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device by internal approach, in patient in amblyogenic developmental stage


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device and using iris expansion device, by internal approach


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device, by internal approach, in patient in amblyogenic developmental stage


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and suprachoroidal aqueous drainage device and using iris expansion device, by internal approach


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and suprachoroidal aqueous drainage device, by internal approach, in patient in amblyogenic developmental stage


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and supraciliary aqueous drainage device and using iris expansion device, by internal approach


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and supraciliary aqueous drainage device, by internal approach, in patient in amblyogenic developmental stage


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device and using iris expansion device, by internal approach


name: Complex mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device, by internal approach, in patient in amblyogenic developmental stage


name: Extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device by internal approach


name: Extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and suprachoroidal aqueous drainage device by internal approach


name: Extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and supraciliary aqueous drainage device by internal approach


name: Extracapsular cataract removal by irrigation and aspiration with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device by internal approach


name: Extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and suprachoroidal aqueous drainage device by internal approach


name: Extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and supraciliary aqueous drainage device by internal approach


name: Extracapsular cataract removal by phacoemulsification with insertion of intraocular lens prosthesis and trabecular meshwork aqueous drainage device by internal approach


name: Manual extracapsular cataract removal with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device by internal approach


name: Mechanical extracapsular cataract removal with insertion of intraocular lens prosthesis and intraocular anterior segment aqueous drainage device by internal approach


name: Cryotherapy of retinal break for prophylaxis of retinal detachment


name: Cryotherapy of retinal lattice degeneration for prophylaxis of retinal detachment


name: Diathermy of retinal break for prophylaxis of retinal detachment


name: Diathermy of retinal lattice degeneration for prophylaxis of retinal detachment


name: Photocoagulation of retinal break for prophylaxis of retinal detachment


name: Photocoagulation of retinal lattice degeneration for prophylaxis of retinal detachment


name: Insertion of drug-eluting implant into lacrimal canaliculus with punctal dilation, each


name: Insertion of drug-eluting implant into lacrimal canaliculus, each


name: Removal and replacement of osseointegrated implant in skull with percutaneous attachment to external speech processor


name: Calculation of trabecular bone score (TBS) of structural condition of bone microarchitecture using dual X-ray absorptiometry (DXA) on gray-scale variogram, with interpretation and report on fracture risk


name: Calculation of trabecular bone score (TBS) of structural condition of bone microarchitecture using imaging data other than dual X-ray absorptiometry (DXA) on gray-scale variogram, with interpretation and report on fracture risk


name: Technical preparation and transmission of data for analysis to be performed elsewhere of trabecular bone score (TBS) of structural condition of bone microarchitecture


name: Technical calculation only of trabecular bone score (TBS) of structural condition of bone microarchitecture


name: Interpretation of trabecular bone score (TBS) of structural condition of bone microarchitecture, with report on fracture risk


name: Pathology clinical consultation for clinical problem, typically 5-20 minutes


name: Pathology clinical consultation for moderately complex clinical problem, typically 21-40 minutes


name: Pathology clinical consultation for highly complex clinical problem, typically 41-60 minutes


name: Prolonged pathology clinical consultation, additional 30 minutes


name: Cytogenomic comparative genomic hybridization (CGH) microarray analysis with interrogation of genomic region for detection of copy number variants


name: Cytogenomic comparative genomic hybridization (CGH) microarray analysis with interrogation of genomic regions for detection of copy number and single nucleotide polymorphism (SNP) variants for chromosomal abnormalities


name: Cytogenomic low-pass sequencing interrogation of genomic regions for copy number and loss-of-heterozygosity variants for detection of constitutional chromosomal abnormalities


name: Level 6 molecular pathology procedure - ATP-binding cassette, subfamily D (ALD), member 1 (ABCD1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Fibroblast growth factor receptor 1 (FGFR1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Growth hormone receptor (GHR) full gene sequence analysis


name: Level 6 molecular pathology procedure - Interleukin 2 receptor, gamma (IL2RG) full gene sequence analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, epsilon (SGCE) deletion analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, epsilon (SGCE) duplication analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, epsilon (SGCE) duplication and deletion analysis


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exons 12, 13, 14, 16, 17, 20, 21


name: Level 6 molecular pathology procedure - Thyroid hormone receptor, beta (THRB) targeted sequence analysis of more than 5 exons


name: Level 6 molecular pathology procedure - gamma-aminobutyric acid (GABA) A receptor, gamma 2 (GABRG2) full gene sequence analysis


name: mRNA gene expression profiling of breast cancer by real-time polymerase chain reaction (RT-PCR) and next-generation sequencing of 70 content genes and 31 housekeeping genes in formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk to distant metastasis


name: Measurement of transplant donor and third-party-induced CD154+T-cytotoxic memory cells in whole peripheral blood, algorithm reported as rejection risk score


name: Quantitative measurement of pancreatic elastase (EL-1) in feces


name: Measurement of free kappa immunoglobulin light chain


name: Measurement of free lambda immunoglobulin light chain


name: Actin smooth muscle antibody (ASMA) detection


name: Antineutrophil cytoplasmic antibody (ANCA) titer


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody detection by enzyme-linked immunosorbent assay (ELISA)


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody detection by cell-based immunofluorescence assay (CBA)


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody detection by fluorescence-activated cell sorting (FACS)


name: Endomysial antibody (EMA) detection, each immunoglobulin class


name: Gliadin (deamidated) (DGP) antibody detection, each immunoglobulin class


name: Myelin oligodendrocyte glycoprotein (MOG-IgG1) antibody detection by cell-based immunofluorescence assay (CBA)


name: Myelin oligodendrocyte glycoprotein (MOG-IgG1) antibody detection by fluorescence-activated cell sorting (FACS)


name: Tissue transglutaminase detection, each immunoglobulin class


name: Measurement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) antibody


name: Voltage-gated calcium channel antibody detection


name: Identification of blood pathogen by multiplexed amplified DNA probe technique, 6 or more targets


name: Identification of blood pathogen by multiplexed amplified DNA probe technique, 6 or more targets, with resistance typing


name: Identification of blood pathogen by multiplexed amplified RNA probe technique, 6 or more targets


name: Identification of blood pathogen by multiplexed amplified RNA probe technique, 6 or more targets, with resistance typing


name: Adenovirus enteric types 40 and 41 antigen detection by qualitative enzyme immunoassay (EIA)


name: Adenovirus enteric types 40 and 41 antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Adenovirus enteric types 40 and 41 antigen detection by qualitative fluorescence immunoassay (FIA)


name: Adenovirus enteric types 40 and 41 antigen detection by qualitative immunoassay


name: Adenovirus enteric types 40 and 41 antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Adenovirus enteric types 40 and 41 antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Adenovirus enteric types 40 and 41 antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Adenovirus enteric types 40 and 41 antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Adenovirus enteric types 40 and 41 antigen detection by semiquantitative immunoassay


name: Adenovirus enteric types 40 and 41 antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Aspergillus antigen detection by qualitative enzyme immunoassay (EIA)


name: Aspergillus antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Aspergillus antigen detection by qualitative fluorescence immunoassay (FIA)


name: Aspergillus antigen detection by qualitative immunoassay


name: Aspergillus antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Aspergillus antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Aspergillus antigen detection by semiquantitative enzyme immunoassay technique


name: Aspergillus antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Aspergillus antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Aspergillus antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Chlamydia trachomatis antigen detection by qualitative enzyme immunoassay (EIA)


name: Chlamydia trachomatis antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Chlamydia trachomatis antigen detection by qualitative fluorescence immunoassay (FIA)


name: Chlamydia trachomatis antigen detection by qualitative immunoassay technique


name: Chlamydia trachomatis antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Chlamydia trachomatis antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Chlamydia trachomatis antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Chlamydia trachomatis antigen detection by semiquantitative immunoassay


name: Chlamydia trachomatis antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Clostridium difficile toxin antigen detection by qualitative enzyme immunoassay (EIA)


name: Clostridium difficile toxin antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Clostridium difficile toxin antigen detection by qualitative fluorescence immunoassay (FIA)


name: Clostridium difficile toxin antigen detection by qualitative immunoassay


name: Clostridium difficile toxin antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Clostridium difficile toxin antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Clostridium difficile toxin antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Clostridium difficile toxin antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Clostridium difficile toxin antigen detection by semiquantitative immunoassay


name: Clostridium difficile toxin antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Cryptococcus neoformans antigen detection by qualitative enzyme immunoassay (EIA)


name: Cryptococcus neoformans antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Cryptococcus neoformans antigen detection by qualitative fluorescence immunoassay (FIA)


name: Cryptococcus neoformans antigen detection by qualitative immunoassay


name: Cryptococcus neoformans antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Cryptococcus neoformans antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Cryptococcus neoformans antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Cryptococcus neoformans antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Cryptococcus neoformans antigen detection by semiquantitative immunoassay


name: Cryptococcus neoformans antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Cryptosporidium antigen detection by qualitative enzyme immunoassay (EIA)


name: Cryptosporidium antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Cryptosporidium antigen detection by qualitative fluorescence immunoassay (FIA)


name: Cryptosporidium antigen detection by qualitative immunoassay


name: Cryptosporidium antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Cryptosporidium antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Cryptosporidium antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Cryptosporidium antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Cryptosporidium antigen detection by semiquantitative immunoassay


name: Cryptosporidium antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Giardia antigen detection by qualitative enzyme immunoassay (EIA)


name: Giardia antigen detection by qualitative immunoassay


name: Giardia antigen detection by qualitative immunoassay enzyme-linked immunosorbent assay (ELISA)


name: Giardia antigen detection by qualitative immunoassay fluorescence immunoassay (FIA)


name: Giardia antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Giardia antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Giardia antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Giardia antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Giardia antigen detection by semiquantitative immunoassay


name: Giardia antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Cytomegalovirus antigen detection by qualitative enzyme immunoassay (EIA)


name: Cytomegalovirus antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Cytomegalovirus antigen detection by qualitative fluorescence immunoassay (FIA)


name: Cytomegalovirus antigen detection by qualitative immunoassay


name: Cytomegalovirus antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Cytomegalovirus antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Cytomegalovirus antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Cytomegalovirus antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Cytomegalovirus antigen detection by semiquantitative immunoassay


name: Cytomegalovirus antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Escherichia coli O157 antigen detection by qualitative enzyme immunoassay (EIA)


name: Escherichia coli O157 antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Escherichia coli O157 antigen detection by qualitative fluorescence immunoassay (FIA)


name: Escherichia coli O157 antigen detection by qualitative immunoassay


name: Escherichia coli O157 antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Escherichia coli O157 antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Escherichia coli O157 antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Escherichia coli O157 antigen detection by semiquantitative immunoassay immunochemiluminometric assay (IMCA)


name: Escherichia coli O157 antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Entamoeba histolytica dispar group antigen detection by qualitative enzyme immunoassay (EIA)


name: Entamoeba histolytica dispar group antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Entamoeba histolytica dispar group antigen detection by qualitative immunoassay


name: Entamoeba histolytica dispar group antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Entamoeba histolytica dispar group antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Entamoeba histolytica dispar group antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Entamoeba histolytica dispar group antigen detection by semiquantitative immunoassay


name: Entamoeba histolytica dispar group antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Entamoeba histolytica dispar group by qualitative fluorescence immunoassay (FIA)


name: Entamoeba histolytica dispar group by qualitative immunochemiluminometric assay (IMCA)


name: Entamoeba histolytica group antigen detection by qualitative enzyme immunoassay (EIA)


name: Entamoeba histolytica group antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Entamoeba histolytica group antigen detection by qualitative fluorescence immunoassay (FIA)


name: Entamoeba histolytica group antigen detection by qualitative immunoassay


name: Entamoeba histolytica group antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Entamoeba histolytica group antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Entamoeba histolytica group antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Entamoeba histolytica group antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Entamoeba histolytica group antigen detection by semiquantitative immunoassay


name: Entamoeba histolytica group antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Helicobacter pylori antigen detection in stool by qualitative enzyme immunoassay (EIA)


name: Helicobacter pylori antigen detection in stool by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Helicobacter pylori antigen detection in stool by qualitative fluorescence immunoassay (FIA)


name: Helicobacter pylori antigen detection in stool by qualitative immunoassay


name: Helicobacter pylori antigen detection in stool by qualitative immunochemiluminometric assay (IMCA)


name: Helicobacter pylori antigen detection in stool by semiquantitative enzyme immunoassay (EIA)


name: Helicobacter pylori antigen detection in stool by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Helicobacter pylori antigen detection in stool by semiquantitative fluorescence immunoassay (FIA)


name: Helicobacter pylori antigen detection in stool by semiquantitative immunoassay


name: Helicobacter pylori antigen detection in stool by semiquantitative immunochemiluminometric assay (IMCA)


name: Helicobacter pylori antigen detection by qualitative enzyme immunoassay (EIA)


name: Helicobacter pylori antigen detection by qualitative fluorescence immunoassay (FIA)


name: Helicobacter pylori antigen detection by qualitative immunoassay


name: Helicobacter pylori antigen detection by qualitative immunoassay enzyme-linked immunosorbent assay (ELISA)


name: Helicobacter pylori antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Helicobacter pylori antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Helicobacter pylori antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Helicobacter pylori antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Helicobacter pylori antigen detection by semiquantitative immunoassay


name: Helicobacter pylori antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Hepatitis B surface antigen (HBsAg) detection by qualitative enzyme immunoassay (EIA)


name: Hepatitis B surface antigen (HBsAg) detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis B surface antigen (HBsAg) detection by qualitative fluorescence immunoassay (FIA)


name: Hepatitis B surface antigen (HBsAg) detection by qualitative immunoassay


name: Hepatitis B surface antigen (HBsAg) detection by qualitative immunochemiluminometric assay (IMCA)


name: Hepatitis B surface antigen (HBsAg) detection by semiquantitative enzyme immunoassay (EIA)


name: Hepatitis B surface antigen (HBsAg) detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis B surface antigen (HBsAg) detection by semiquantitative fluorescence immunoassay (FIA)


name: Hepatitis B surface antigen (HBsAg) detection by semiquantitative immunoassay


name: Hepatitis B surface antigen (HBsAg) detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Hepatitis B surface antigen (HBsAg) neutralization by qualitative enzyme immunoassay (EIA)


name: Hepatitis B surface antigen (HBsAg) neutralization by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis B surface antigen (HBsAg) neutralization by qualitative fluorescence immunoassay (FIA)


name: Hepatitis B surface antigen (HBsAg) neutralization by qualitative immunoassay


name: Hepatitis B surface antigen (HBsAg) neutralization by semiquantitative enzyme immunoassay (EIA)


name: Hepatitis B surface antigen (HBsAg) neutralization by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis B surface antigen (HBsAg) neutralization by semiquantitative fluorescence immunoassay (FIA)


name: Hepatitis B surface antigen (HBsAg) neutralization by semiquantitative immunoassay


name: Hepatitis Be (HBeAg) detection by qualitative enzyme immunoassay (EIA)


name: Hepatitis Be (HBeAg) detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis Be (HBeAg) detection by qualitative fluorescence immunoassay (FIA)


name: Hepatitis Be (HBeAg) detection by qualitative immunoassay


name: Hepatitis Be (HBeAg) detection by semiquantitative enzyme immunoassay (EIA)


name: Hepatitis Be (HBeAg) detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis Be (HBeAg) detection by semiquantitative fluorescence immunoassay (FIA)


name: Hepatitis Be (HBeAg) detection by semiquantitative immunoassay immunochemiluminometric assay (IMCA)


name: Hepatitis Be (HBeAg) detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Hepatitis delta agent antigen detection by qualitative enzyme immunoassay (EIA)


name: Hepatitis delta agent antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis delta agent antigen detection by qualitative fluorescence immunoassay (FIA)


name: Hepatitis delta agent antigen detection by qualitative immunoassay


name: Hepatitis delta agent antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Hepatitis delta agent antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Hepatitis delta agent antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Hepatitis delta agent antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Hepatitis delta agent antigen detection by semiquantitative immunoassay


name: Hepatitis delta agent antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Histoplasma capsulatum antigen detection by qualitative enzyme immunoassay (EIA)


name: Histoplasma capsulatum antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Histoplasma capsulatum antigen detection by qualitative fluorescence immunoassay (FIA)


name: Histoplasma capsulatum antigen detection by qualitative immunoassay


name: Histoplasma capsulatum antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Histoplasma capsulatum antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Histoplasma capsulatum antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Histoplasma capsulatum antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Histoplasma capsulatum antigen detection by semiquantitative immunoassay


name: Histoplasma capsulatum antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by qualitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by qualitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by qualitative immunoassay


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by qualitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by semiquantitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by semiquantitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by semiquantitative immunoassay


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by qualitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by qualitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by qualitative immunoassay


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by semiquantitative immunoassay


name: Human immunodeficiency virus type 1 (HIV-1) antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by qualitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by qualitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by qualitative immunoassay


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by semiquantitative immunoassay


name: Human immunodeficiency virus type 2 (HIV-2) antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Influenza A antigen detection by qualitative enzyme immunoassay (EIA)


name: Influenza A antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Influenza A antigen detection by qualitative fluorescence immunoassay (FIA)


name: Influenza A antigen detection by qualitative immunoassay


name: Influenza A antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Influenza A antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Influenza A antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Influenza A antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Influenza A antigen detection by semiquantitative immunoassay


name: Influenza A antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Respiratory syncytial virus antigen detection by qualitative enzyme immunoassay (EIA)


name: Respiratory syncytial virus antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Respiratory syncytial virus antigen detection by qualitative fluorescence immunoassay (FIA)


name: Respiratory syncytial virus antigen detection by qualitative immunoassay


name: Respiratory syncytial virus antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Respiratory syncytial virus antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Respiratory syncytial virus antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Respiratory syncytial virus antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Respiratory syncytial virus antigen detection by semiquantitative immunoassay


name: Respiratory syncytial virus antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Rotavirus antigen detection by qualitative enzyme immunoassay (EIA)


name: Rotavirus antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Rotavirus antigen detection by qualitative fluorescence immunoassay (FIA)


name: Rotavirus antigen detection by qualitative immunoassay


name: Rotavirus antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Rotavirus antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Rotavirus antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Rotavirus antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Rotavirus antigen detection by semiquantitative immunoassay


name: Rotavirus antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by enzyme immunoassay (EI)


name: Qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by enzyme-linked immunoassay (ELISA)


name: Qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by fluorescence immunoassay (FIA)


name: Qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by immunoassay


name: Qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by immunochemiluminometric assay (IMCA)


name: Semiquantitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by enzyme immunoassay (EI)


name: Semiquantitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by enzyme-linked immunoassay (ELISA)


name: Semiquantitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by fluorescence immunoassay (FIA)


name: Semiquantitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by immunoassay


name: Semiquantitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B antigen by immunochemiluminometric assay (IMCA)


name: Shiga-like toxin antigen detection by qualitative


name: Shiga-like toxin antigen detection by qualitative enzyme immunoassay (EIA)


name: Shiga-like toxin antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Shiga-like toxin antigen detection by qualitative fluorescence immunoassay (FIA)


name: Shiga-like toxin antigen detection by qualitative immunoassay


name: Shiga-like toxin antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Shiga-like toxin antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Shiga-like toxin antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Shiga-like toxin antigen detection by semiquantitative immunoassay


name: Shiga-like toxin antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Group A Streptococcus antigen detection by qualitative enzyme immunoassay (EIA)


name: Group A Streptococcus antigen detection by qualitative enzyme-linked immunosorbent assay (ELISA)


name: Group A Streptococcus antigen detection by qualitative fluorescence immunoassay (FIA)


name: Group A Streptococcus antigen detection by qualitative immunoassay


name: Group A Streptococcus antigen detection by qualitative immunochemiluminometric assay (IMCA)


name: Group A Streptococcus antigen detection by semiquantitative enzyme immunoassay (EIA)


name: Group A Streptococcus antigen detection by semiquantitative enzyme-linked immunosorbent assay (ELISA)


name: Group A Streptococcus antigen detection by semiquantitative fluorescence immunoassay (FIA)


name: Group A Streptococcus antigen detection by semiquantitative immunoassay


name: Group A Streptococcus antigen detection by semiquantitative immunochemiluminometric assay (IMCA)


name: Qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B antigen by multiplex amplified DNA probe


name: Qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B antigen by multiplex amplified RNA probe


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus antigen by multiplex amplified DNA probe


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus antigen by multiplex amplified RNA probe


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) by immunoassay with direct optical observation


name: Prescription drug monitoring panel of 31 drugs in blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS), reported as quantitative results, detected or not detected, per date of service


name: Prescription drug monitoring panel of 31 drugs in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS), reported as quantitative results, detected or not detected, per date of service


name: Untargeted next-generation sequencing of infectious disease agent cell-free DNA in plasma specimen, report for significant positive pathogens


name: Presumptive drug testing for 30 or more drugs or metabolites in urine by liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring (MRM), with drug or metabolite description and sample validation


name: Multianalyte molecular profile by photometric detection of macromolecules adsorbed on nanosponge array slides with machine learning, in first morning voided urine, algorithm reported as likelihood of prostate cancer


name: Androgen receptor (AR) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions


name: Calcium voltage-gated channel subunit alpha 1A (CACNA1A) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions


name: Cystatin B (CSTB) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions


name: Frataxin (FXN) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions


name: Methyl CpG binding protein 2 (MECP2) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions


name: Phosphatase and tensin homolog (PTEN) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions


name: Survival of motor neuron 1, telomeric (SMN1) and survival of motor neuron 2, centromeric (SMN2) full gene sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, and mobile element insertions


name: Cardiac ion channelopathie genomic sequence analysis panel including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions


name: Genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions


name: Targeted genomic sequence analysis panel analysis of 311 or more genes associated with solid organ neoplasm in cell-free DNA, with interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, and influenza B RNA in upper respiratory specimen, each pathogen reported as detected or not detected


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, influenza B, and respiratory syncytial virus (RSV) RNA in upper respiratory specimen, each pathogen reported as detected or not detected


name: Targeted genomic sequence analysis panel analysis of 55-74 genes associated with solid organ neoplasm in circulating cell-free DNA, with interrogation for sequence variants, gene copy number amplifications, and gene rearrangements


name: Biochemical assay of placental-growth factor by time-resolved fluorescence immunoassay in maternal serum, predictive algorithm reported as risk score for preeclampsia


name: Comprehensive DNA genomic profiling of 257 genes with interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearrangements, tumor-mutational burden and microsatellite instability in formalin-fixed paraffin-embedded tumor tissue


name: Mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing in fine needle aspirate of thyroid, report includes associated risk of thyroid malignancy expressed as a percentage


name: Red blood cell (RBC) antigen DNA genotyping of at least 16 blood groups with phenotype prediction of at least 51 red blood cell antigens


name: Quantitative measurement of insulin-like growth factor-binding protein 4 (IBP4) and sex hormone-binding globulin (SHBG) liquid chromatography-tandem mass spectrometry (LC-MS/MS), in maternal serum, combined with clinical data, reported as predictive-risk stratification for spontaneous preterm birth


name: Semiquantitative analysis of 32 phosphoproteins and protein analytes associated with breast cancer, with laser capture microdissection, with algorithmic analysis and interpretative report


name: Targeted genomic sequence DNA analysis of 505 genes, with interrogation for somatic alterations (SNVs [single nucleotide variant], small insertions and deletions, one amplification, and four translocations), microsatellite instability and tumor-mutation burden


name: Detection of hepcidin-25 by enzyme-linked immunosorbent assay (ELISA) in plasma


name: Detection of hepcidin-25 by enzyme-linked immunosorbent assay (ELISA) in serum


name: Fetal aneuploidy short tandem-repeat comparative analysis of fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy


name: RNA gene expression profiling of 238 genes by next-generation sequencing in endometrial tissue for endometrial receptivity analysis, predictive algorithm reported as endometrial window of implantation


name: Preimplantation analysis of 24 chromosomes using embryonic DNA genomic sequence analysis for aneuploidy, and a mitochondrial DNA score in euploid embryos, results reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy, per embryo tested


name: Sperm-capacitation assessment of ganglioside GM1 distribution patterns by fluorescence microscopy in fresh semen specimen, reported as percentage of capacitated sperm and probability of generating pregnancy score


name: Sperm-capacitation assessment of ganglioside GM1 distribution patterns by fluorescence microscopy in frozen semen specimen, reported as percentage of capacitated sperm and probability of generating pregnancy score


name: Trimethylamine/trimethylamine N-oxide (TMA/TMAO) profiling by tandem mass spectrometry (MS/MS) in urine, with algorithmic analysis and interpretive report


name: Very long chain acyl-coenzyme A (CoA) dehydrogenase (VLCAD) leukocyte enzyme activity in whole blood


name: Next-generation sequencing with mRNA gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likelihood of response to psoriasis biologics


name: Quantitative measurement of myo-inositol, valine, and creatinine in serum by nuclear magnetic resonance spectroscopy , algorithmically combined with cystatin C (by immunoassay) and demographic data to determine estimated glomerular filtration rate (GFR)


name: Optical genome mapping for detection of copy number variations, inversions, insertions, translocations, and other structural variants associated with rare constitutional and heritable disorders


name: Image analysis with artificial intelligence assessment of 4 histologic and immunohistochemical features (CD3 and CD8 within tumor-stroma border and tumor core) in colon tumor tissue, reported as immune response and recurrence-risk score


name: Gene expression profiling by real-time polymerase chain reaction (RT-PCR) of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch) in formalin-fixed paraffin-embedded tissue specimen, algorithm reported as gene pathway activity score


name: Quantitative measurement of 16 central carbon metabolites (α-ketoglutarate, alanine, lactate, phenylalanine, pyruvate, succinate, carnitine, citrate, fumarate, hypoxanthine, inosine, malate, S-sulfocysteine, taurine, urate, and xanthine) by liquid chromatography tandem mass spectrometry (LC-MS/MS) in plasma, with algorithmic analysis result reported as negative or positive (with metabolic subtypes of autism spectrum disorder)


name: Optical genome mapping for detection of copy number variations, inversions, insertions, translocations, and other structural variants


name: Whole genome and mitochondrial DNA sequence analysis for detection of single nucleotide and copy number variants associated with rare constitutional and hereditary disorders in blood


name: Whole genome and mitochondrial DNA sequence analysis for detection of single nucleotide and copy number variants associated with rare constitutional and hereditary disorders in buccal swabs


name: Whole genome and mitochondrial DNA sequence analysis for detection of single nucleotide and copy number variants associated with rare constitutional and hereditary disorders in cell lines


name: Whole genome and mitochondrial DNA sequence analysis for detection of single nucleotide and copy number variants associated with rare constitutional and hereditary disorders in frozen and formalin-fixed paraffin-embedded tissue


name: Whole genome and mitochondrial DNA sequence analysis for detection of single nucleotide and copy number variants associated with rare constitutional and hereditary disorders in saliva


name: Tissue-specific gene expression profiling by whole-transcriptome and next-generation sequencing in blood, for unexplained constitutional or heritable disorders, reported as presence or absence of splicing or expression changes


name: Tissue-specific gene expression profiling by whole-transcriptome and next-generation sequencing in formalin-fixed paraffin-embedded tissue, for unexplained constitutional or heritable disorders, reported as presence or absence of splicing or expression changes


name: Tissue-specific gene expression profiling by whole-transcriptome and next-generation sequencing in fresh frozen tissue, for unexplained constitutional or heritable disorders, reported as presence or absence of splicing or expression changes


name: Optical genome mapping and nd whole genome sequencing for detection of copy number variations, inversions, insertions, translocations, and other structural variants associated with rare constitutional and heritable disorders


name: Genomic sequence analysis of 15 genes associated with atypical hemolytic uremic syndrome (aHUS) in amniotic fluid


name: Genomic sequence analysis of 15 genes associated with atypical hemolytic uremic syndrome (aHUS) in blood


name: Genomic sequence analysis of 15 genes associated with atypical hemolytic uremic syndrome (aHUS) in buccal swab


name: Genomic sequence analysis of 20 genes associated with congenital coagulation disorders in amniotic fluid


name: Genomic sequence analysis of 20 genes associated with congenital coagulation disorders in blood


name: Genomic sequence analysis of 20 genes associated with congenital coagulation disorders in buccal swab


name: Genomic sequence analysis of 8 genes associated with genetic hyperfibrinolysis and delayed bleeding (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2, PLAU) in , buccal swab


name: Genomic sequence analysis of 8 genes associated with genetic hyperfibrinolysis and delayed bleeding (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2, PLAU) in amniotic fluid


name: Genomic sequence analysis of 8 genes associated with genetic hyperfibrinolysis and delayed bleeding (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2, PLAU) in blood


name: Evaluation of platelet antibody reactivity by flow cytometry in serum


name: Genomic sequence analysis of 31 genes associated with genetic platelet function disorder in buccal swab


name: Detection of von Willebrand factor (VWF) and collagen III binding by enzyme-linked immunosorbent assays (ELISA) in plasma, with report of collagen III binding


name: Detection of von Willebrand factor (VWF) and collagen IV binding by enzyme-linked immunosorbent assays (ELISA) in plasma, with report of collagen IV binding


name: Detection of von Willebrand propeptide by enzyme-linked immunosorbent assay (ELISA) in plasma, with diagnostic report of von Willebrand factor (VWF) propeptide antigen level


name: Red blood cell (RBC) antigen DNA genotyping of 12 blood group system genes to predict 44 red blood cell antigen phenotypes


name: von Willebrand factor (VWF) type 2B platelet-binding evaluation by radioimmunoassay in plasma


name: von Willebrand factor (VWF), type 2N, factor VIII and VWF binding evaluation by enzyme-linked immunosorbent assays (ELISA) in plasma


name: Capsule endoscopy imaging of colon, with interpretation and report


name: Intraluminal imaging of colon, with interpretation and report


name: 3D echocardiographic imaging and postprocessing during transesophageal echocardiography for assessment of cardiac structure


name: 3D echocardiographic imaging and postprocessing during transesophageal echocardiography for assessment of cardiac structure and function


name: 3D echocardiographic imaging and postprocessing during transthoracic echocardiography for assessment of cardiac structure


name: 3D echocardiographic imaging and postprocessing during transthoracic echocardiography for assessment of cardiac structure and function


name: Right heart catheterization for congenital heart defect with normal native connections, using imaging guidance by proceduralist


name: Right heart catheterization for congenital heart defect with abnormal native connections, using imaging guidance by proceduralist


name: Left heart catheterization for congenital heart defect using imaging guidance by proceduralist


name: Right and left heart catheterization for congenital heart defect with normal native connections, using imaging guidance by proceduralist


name: Right and left heart catheterization for congenital heart defect with abnormal native connections, using imaging guidance by proceduralist


name: Measurement of cardiac output by indicator dilution method, performed during cardiac catheterization for evaluation of congenital heart defects


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, right atrial pacing and recording, and treatment of supraventricular tachycardia by ablation of single atrial focus


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, with treatment of supraventricular tachycardia by intracardiac catheter ablation of accessory atrioventricular connection


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, with treatment of supraventricular tachycardia by intracardiac catheter ablation of cavo-tricuspid isthmus


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, with treatment of supraventricular tachycardia by intracardiac catheter ablation of fast atrioventricular pathway


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, with treatment of supraventricular tachycardia by intracardiac catheter ablation of single source of atrial re-entry


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, with right atrial pacing and recording, with treatment of supraventricular tachycardia by intracardiac catheter ablation of slow atrioventricular pathway


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, right atrial and left ventricular pacing and recording, and intracardiac catheter ablation of focus of ventricular ectopy


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, right atrial and left ventricular pacing and recording, and treatment of ventricular tachycardia by intracardiac catheter ablation of arrhythmogenic focus


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, right atrial pacing and recording, and intracardiac catheter ablation of focus of ventricular ectopy


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, with induction of arrhythmia, right atrial pacing and recording, and treatment of ventricular tachycardia by intracardiac catheter ablation of arrhythmogenic focus


name: Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation


name: Health care professional services for outpatient pulmonary rehabilitation


name: Health care professional services for outpatient pulmonary rehabilitation with continuous oximetry


name: Remote therapeutic monitoring treatment management services by health care professional time in calendar month requiring at least one interactive communication with the patient or caregiver; first 20 minutes


name: Remote therapeutic monitoring treatment management services by health care professional time in calendar month requiring at least one interactive communication with the patient or caregiver; each additional 20 minutes


name: Additional supplies, materials, and clinical staff time over and above those usually included in an office visit, when performed during Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease


name: Additional supplies, materials, and clinical staff time over and above those usually included in non-facility services, when performed during Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease


name: Office or Other Outpatient Consultations


name: Behavior Change Interventions, Individual


name: Online Digital Evaluation and Management Services


name: Pediatric Critical Care Patient Transport


name: Inpatient Neonatal and Pediatric Critical Care


name: Complex Chronic Care Management Services


name: Complex chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored, moderate or high complexity medical decision making


name: Anesthesia for percutaneous image-guided neuromodulation or intravertebral procedures (eg, kyphoplasty, vertebroplasty) on the spine or spinal cord


name: Foreign Body/Implant Definition (Surgery)


name: Introduction or Removal Procedures on the Head


name: Arthrodesis, posterior or posterolateral technique, single interspace


name: Introduction or Removal (Injection) Procedures on the Leg (Tibia and Fibula) and Ankle Joint


name: Bronchial Thermoplasty Procedures on the Trachea and Bronchi


name: Transcatheter intracardiac shunt (TIS) creation by stent placement for congenital cardiac anomalies to establish effective intracardiac flow, including all imaging guidance by the proceduralist, when performed, left and right heart diagnostic cardiac catheterization for congenital cardiac anomalies, and target zone angioplasty, when performed (eg, atrial septum, Fontan fenestration, right ventricular outflow tract, Mustard/Senning/Warden baffles)


name: Endovascular Repair of Congenital Heart and Vascular Defects


name: Endovascular stent repair of coarctation of the ascending, transverse, or descending thoracic or abdominal aorta, involving stent placement


name: Introduction (Injection) Procedure on the Spleen


name: Laparoscopic Excision Procedures on the Rectum


name: Periurethral transperineal adjustable balloon continence device


name: Other Procedures on the Parathyroid, Thymus, Adrenal Glands, Pancreas, and Carotid Body


name: Laser interstitial thermal therapy (LITT) of lesion, intracranial, including burr hole(s), with magnetic resonance imaging guidance, when performed


name: Laminectomy, facetectomy, or foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s] [eg, spinal or lateral recess stenosis]), during posterior interbody arthrodesis, lumbar


name: Open implantation of neurostimulator electrode array


name: Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance


name: Aqueous Shunt Procedures on the Anterior Sclera of the Eye


name: Prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage


name: Foreign Body/Implant Definition (Radiology)


name: Trabecular bone score (TBS), structural condition of the bone microarchitecture


name: Instructions for Selecting a Level of Pathology Clinical Consultation Services


name: Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody


name: Myelin oligodendrocyte glycoprotein (MOG-IgG1) antibody


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative


name: Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation


name: Foreign Body/Implant Definition (Medicine)


name: Tick-borne encephalitis virus vaccine, inactivated


name: Coronary Therapeutic Services and Procedures


name: Transcatheter Closure of Paravalvular Leak


name: Cardiac Catheterization for Congenital Heart Defects


name: Right heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone


name: Right and left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone(s)


name: Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia with right atrial pacing and recording and catheter ablation of arrhythmogenic focus, including intracardiac electrophysiologic 3-dimensional mapping, right ventricular pacing and recording, left atrial pacing and recording from coronary sinus or left atrium, and His bundle recording, when performed


name: Noninvasive Physiologic Studies and Procedures


name: Pulmonary Diagnostic Testing, Rehabilitation, and Therapies


name: Physician or other qualified health care professional services for outpatient pulmonary rehabilitation


name: Psychological and Neuropsychological Testing with Automated Testing and Result


name: Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent Administration


name: Remote Therapeutic Monitoring Treatment Management Services


name: Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month


name: Extracorporeal shock wave for integumentary wound healing, including topical application and dressing care


name: Adaptive Behavior Assessments and Treatment


name: Pacemaker-Leadless and Pocketless System


name: Phrenic Nerve Stimulation System (procedure)


name: Wireless Cardiac Stimulation System for Left Ventricular Pacing


name: Implantable Cardioverter-Defibrillator with Substernal Electrode


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure)


name: Donor hysterectomy (including cold preservation)


name: Backbench reconstruction of cadaver or living donor uterus allograft prior to transplantation


name: Implantable Synchronized Diaphragmatic Stimulation System for Augmentation of Cardiac Function


name: Laparoscopic insertion of new or replacement of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator


name: Laparoscopic repositioning of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator


name: Treatment of amblyopia using an online digital program


name: Body surface-activation mapping of pacemaker or pacing cardioverter-defibrillator lead(s) to optimize electrical synchrony, cardiac resynchronization therapy device, including connection, recording, disconnection, review, and report


name: Molecular fluorescent imaging of suspicious nevus


name: Remote treatment of amblyopia using an eye tracking device


name: Noninvasive arterial plaque analysis using software processing of data from non-coronary computerized tomography angiography


name: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) Vaccines


name: Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])


name: DermacinRx Vitrexate Multivitamin Caplet


name: DermacinRx Vitrexyl + Iron Multivitamin Tablet


name: HEB inControl UltiCare 31G 1/4 inch Mini Pen Needle


name: HEB inControl UltiCare 31G 5/16 inch Short Pen Needle


name: HEB inControl Ulticare 32G 5/32 inch Micro Pen Needle


name: SILINOIN Medical-Grade 8-Day Silicone Gel Sheet


name: Zenoptiq 0.0085% Daily Eyelid & Eyelash Hygiene Gel Solution


name: Zenoptiq 0.01% Daily Eyelid & Eyelash Hygiene Spray Solution


name: Capsaicin;Diclofenac Sodium 0.025%; 1.5% Multiple Routes Kit [ZICLOCIN]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Finzala 24 Fe Chewable 28 Day]


name: Permethrin;Solution, Multi Ingredient 0.25%; NA Multiple Routes Kit [NIX ULTRA LICE REMOVAL KIT]


name: Cetaphil Advanced Relief With Shea Butter


name: omega-3 polyunsaturated fatty acids-turmeric


name: Aquaphor Lip Protectant And Sunscreen SPF 30


name: Aquaphor Lip Repair Stick Sunscreen SPF 30


name: Band-Aid Sensitive Skin Adhesive Bandages


name: Coppertone Complete Sunscreen Lotion SPF 30


name: Coppertone Complete Sunscreen Spray SPF 30


name: Coppertone Complete Sunscreen Spray SPF 50


name: Coppertone Glow Shimmer Sunscreen SPF 50


name: Coppertone Glow Sunscreen And Tanner SPF 30


name: Coppertone Kids Sport Sunscreen Spray SPF 100


name: Coppertone Kids Sport Sunscreen Spray SPF 50


name: Coppertone Kids Tear Free Sunscreen SPF 50


name: Coppertone Oil Free Face Sunscreen SPF 30


name: Coppertone Protect And Tan Sunscreen SPF 45


name: Coppertone Pure And Simple Sunscreen SPF 50


name: Coppertone Pure Simple Baby Sunscreen SPF 50


name: Coppertone Pure Simple Kids Sunscreen SPF 50


name: Coppertone Pure Simple Sunscreen Spray SPF 50


name: Coppertone Pure Simple Sunscreen Stick SPF 50


name: Coppertone Sport Mineral Sunscreen SPF 50


name: Eucerin Advanced Hydration Sunscreen SPF 50


name: Eucerin Baby Sensitive Mineral SPF 50 Lotion


name: Eucerin Redness Relief Day Lotion SPF 15


name: Oral-B Pro-Flex Charcoal Medium Toothbrush


name: Oral-B Pro-Flex Charcoal Soft Toothbrush


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-5%-4.5%-3% Topical application Lotion [COPPERTONE SPORT 4IN1 15 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-5%-4.5%-3% Topical application Lotion [COPPERTONE TANNING 15 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-5%-4.5%-3% Topical application Lotion [COPPERTONE TANNING 8 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-8%-4.5%-7% Topical application Spray [COPPERTONE COMPLETE 30 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-10%-4.5%-8% Topical application Lotion [COPPERTONE OIL-FREE FACE 50 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-10%-4.5%-8% Topical application Lotion [COPPERTONE SPORT 4IN1 50 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-14%-4.5%-9% Topical application Lotion [COPPERTONE GLOW PROTECT & TAN 30 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-8%-4.5%-6% Topical application Lotion [COPPERTONE SPORT 4IN1 30 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-9%-4.5%-9% Topical application Lotion [COPPERTONE COMPLETE 50 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-9%-4.5%-9% Topical application Spray [COPPERTONE WATERBABIES 50 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene/Oxybenzone 3%-13%-5%-10%-6% Topical application Lotion [COPPERTONE SPORT 4IN1 70 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene/Oxybenzone 3%-15%-5%-10%-6% Topical application Lotion [COPPERTONE SPORT 4IN1 100 SUNSCREEN]


name: Avobenzone/Octisalate/Octocrylene 2%-4.5%-7% Topical application Spray [COPPERTONE TANNING 15 SUNSCREEN]


name: Cleanser Topical application Solution [MONISTAT MAINTAIN FEMININE CLEANSER]


name: Cleanser Topical application Solution [SUMMER'S EVE ACTIVE CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE ALOE LOVE CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE BLISSFUL ESCAPE WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE GOLDEN GLAMOUR CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE ISLAND SPLASH CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE NIGHT-TIME CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE SHEER FLORAL CLEANSING WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE ULTIMATE WASH]


name: Cleanser Topical application Solution [SUMMER'S EVE SPA WASH]


name: Powder, Multi Ingredient Topical application Powder [SUMMER'S EVE ISLAND SPLASH]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE ACTIVE CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE ALOE LOVE CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE BLISSFUL ESCAPE CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE GOLDEN GLAMOUR CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE ISLAND SPLASH CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE SIMPLY SENSITIVE CLEANSING CLOTHS]


name: Solution, Multi Ingredient Topical application Solution [SUMMER'S EVA SPA SERUM]


name: Spray, Multi Ingredient Topical application Spray [SUMMER'S EVE ACTIVE]


name: Spray, Multi Ingredient Topical application Spray [SUMMER'S EVE FRESHENING]


name: Zinc Oxide 24.08% Topical application Lotion [COPPERTONE SPORT MINERAL 50 SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-14%-4.5%-9% Topical application Lotion


name: Avobenzone/Octisalate/Octocrylene 3%-2%-10% Topical application Lotion


name: Permethrin;Solution, Multi Ingredient 0.25%; NA Multiple Routes Kit


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [CIEN SUN BY LIDL SPORT SUNSCREEN SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [CVS Health Sport SPF 30 Clear Broad Spectrum]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [EQUALINE SPORT SUNSCREEN CONTINUOUS SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [EXCHANGE SELECT SPORT SUNSCREEN CONTINUOUS SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [CIEN SUN BY LIDL KIDS SUNSCREEN SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [EQUALINE KIDS SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [EXCHANGE SELECT KIDS SPF 50]


name: Aluminum Sesquichlorohydrate 0.15 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant Underarm Cucumber Splash Scent]


name: HOMOSALATE 100 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [CVS Health Kids SPF 50 Clear]


name: HOMOSALATE 13 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 6 g in 100 g / AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL LOTION [Coppertone Sport Sunscreen SPF 70]


name: OCTOCRYLENE 6 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Coppertone Oil Free Sunscreen SPF 30]


name: ZINC OXIDE 94 mg in 1 g TOPICAL STICK [Curology The Lip Balm Broad Spectrum SPF 30 Sunscreen]


name: ZINC OXIDE 94 mg in 1 mL TOPICAL CREAM [Curology the sunscreen broad spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [WALGREENS SPORT CONTINUOUS SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [WEGMANS SPORT CLEAR CONTINUOUS SUNSCREEN SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [BIG LOTS SOUNDBODY KIDS SUNSCREEN SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 28 mg in 1 mL TOPICAL CREAM [PLANTSCRIPTION SPF 25 POWER ANTI AGING BROAD SPECTRUM 25]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL AEROSOL, SPRAY [HARMON FACE VALUES ULTRA SPORT ACTIVE SUNSCREEN SPF 30]


name: HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 30 mg in 1 g / AVOBENZONE 20 mg in 1 g TOPICAL STICK [PRIDEFUL SPF 15 LIP BALM-cherry vanilla]


name: ZINC OXIDE 12.81 g in 12.81 g TOPICAL EMULSION [Sunscreen]


name: ZINC OXIDE 180 mg in 1 g TOPICAL CREAM [PROTEKT SPF-50 Sheer Mineral Sunscreen]


name: ZINC OXIDE 180 mg in 1 mL TOPICAL CREAM [PROTEKT SPF-50 Sheer Mineral Sunscreen]


name: AVOBENZONE 15 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Aveeno Positively Radiant Daily Moisturizer Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 115 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL TOPICAL LOTION [Aveeno Positively Radiant Daily Moisturizer Sunscreen Broad Spectrum SPF 15]


name: OCTINOXATE 67 mg in 1 mL / TITANIUM DIOXIDE 11 mg in 1 mL TOPICAL LOTION [Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 20 Sunscreen Luminous Matte Foundation]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LIQUID [TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30 Deep Cool]


name: ZINC OXIDE 10 g in 100 g TOPICAL STICK [Attitude - Leaves Bar - Lip Balm - SPF 15 - Mango]


name: TITANIUM DIOXIDE 57.5 mg in 1 g / ZINC OXIDE 49 mg in 1 g TOPICAL POWDER [LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 ARENA 200]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [Clove Hill acne safe mineral sunscreen SPF 40]


name: CHLOROXYLENOL 0.3 g in 100 mL TOPICAL LIQUID [Great Value ULTRA DISH Liquid Antibacterial HANDSOAP crisp apple]


name: HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL OIL [Glow Go Lip Oil]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 10 mg in 1 mL / OXYBENZONE 50 mg in 1 mL TOPICAL CREAM [Sensitif Renewal Cream Daily Protection SPF 30 Broad Spectrum UVA UVB Sunscreen]


name: OCTINOXATE 50 mg in 1 mL / TITANIUM DIOXIDE 31 mg in 1 mL / ZINC OXIDE 22 mg in 1 mL TOPICAL LIQUID [DOUBLE WEAR NUDE WATER FRESH MAKEUP BROAD SPECTRUM SPF 30]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Eco Lips Zinc Sunscreen Lip Balm Broad Spectrum SPF 15 Coconut Vanilla]


name: Alcohol 20 mL in 100 mL TOPICAL LIQUID [ROUND AROUND CYPRESS CLEAN SP RAY CYPRESS FOREST]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Stay Ageless Daily Moisturizing Sunscreen Broad Spectrum SPF 25]


name: TITANIUM DIOXIDE 63 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [DR ANDREW WEILS FOR ORIGINS MEGA-DEFENSE ADVANCED DAILY UV DEFENDER BROAD SPECTRUM SPF 45]


name: AVOBENZONE 690 mg in 30 mL / HOMOSALATE 3000 mg in 30 mL / OCTISALATE 1500 mg in 30 mL / OCTOCRYLENE 1500 mg in 30 mL TOPICAL EMULSION [SHISEIDO URBAN ENVIRONMENT VITA-CLEAR SUNSCREEN]


name: OCTINOXATE 7.5 g in 100 g / OCTOCRYLENE 5 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [Eco Lips PlantPod Sunscreen Lip Balm Berry SPF 15]


name: OCTINOXATE 7.5 g in 100 g / OXYBENZONE 4 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL STICK [Eco Lips PlantPod Sunscreen Lip Balm Sport SPF 30]


name: NIACINAMIDE 2.0 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL CREAM [JUVEHEAL Hydro Synergy Liposome Barrier]


name: NIACINAMIDE 2.0 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [JUVEHEAL Hydro Synergy Balancing LHA Toner]


name: NIACINAMIDE 2.0 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [JUVEHEAL Hydro Synergy Intensive Serum]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL SPRAY [Garnier Ombrelle Sport Vaporisateur Broad Spectrum SPF 30 Sweat Resistant 80 Minutes]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 8 g in 100 mL / OCTISALATE 4 g in 100 mL / OCTOCRYLENE 5 g in 100 mL TOPICAL CREAM [Bevel Hair Mattifying Bald Balm with Sunscreen SPF 25]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 70 mg in 1 g TOPICAL SPRAY [Premium Moisturizing Sunscreen SPF 50]


name: Titanium Dioxide 40 mg in 1 g / Zinc Oxide 55 mg in 1 g TOPICAL STICK [CoTZ Mineral Suns Stick - Tinted SPF 45]


name: ALUMINUM SESQUICHLOROHYDRATE 12.2 g in 100 g TOPICAL STICK [Dove]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 20 g in 100 g TOPICAL GEL [Gillette Clinical Protection Cool Wave Clear]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 6 g in 100 mL TOPICAL CREAM [Derma Geek Nourishing Facial Moisturizer with Sunscreen Broad Spectrum SPF 30]


name: TITANIUM DIOXIDE 7.552 mg in 118 g / ZINC OXIDE 17.7 mg in 118 g TOPICAL CREAM [ZO Skin Health Broad-Spectrum Sunscreen SPF 50]


name: {63 (pirfenidone 267 MG Oral Capsule) } Pack


name: digital therapeutics,cognit. behavioral therapy for ADHD MISCELL MISCELLANEOUS


name: digital therapeutics,cognit. behavioral therapy for IBS MISCELL MISCELLANEOUS


name: digital therapeutics,cognit. behavioral therapy for OUD MISCELL MISCELLANEOUS


name: digital therapeutics,cognit. behavioral therapy for SUD MISCELL MISCELLANEOUS


name: digital therapeutics,cognit. behavioral therapy for insomnia MISCELL MISCELLANEOUS


name: pen needle, diabetic disposable, safety 32 gauge X 5/32" MISCELL NEEDLE, DISPOSABLE


name: pen needle, diabetic, safety 31 gauge X 5/32" MISCELL NEEDLE, DISPOSABLE


name: thrombin(human plasma derived)/gelatin matrix, bovine 2,500 unit TOPICAL KIT


name: EUA patient assessment MISCELL MISCELLANEOUS


name: cryotherapy wart removal device TOPICAL EACH


name: digital therapeutics, urinary incontinence


name: magnesium amino acid chelate, L-threonate, malate


name: magnesium amino acid chelate, magnesium malate


name: calcium carbonate, calcium phosphate dibasic


name: DRESSING,MEPILEX BORDER POST-OP AG 4IN X 12IN #498600


name: DRESSING,MEPILEX BORDER POST-OP AG 4IN X 10IN #498450


name: TRACH TUBE,SZ 9 CUFFLESS BIVONA SMITHS #60A190


name: DRESSING,HYDROFERA BLUE 4IN X 4IN HBRB4040


name: DRESSING,HYDROFERA BLUE 6IN X 8IN HBRB6080


name: DRESSING,URGOTUL SILVER 8IN X 16IN #553228


name: TRACH TUBE,SZ 6 CUFFLESS/FEN SMITH DIC #512060


name: DRESSING,OPTIFOAM AG GENTLE BORDER 4IN X 4IN #MSC9744


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DT18695


name: CATHETER,INTERMITTENT 10FR FEMALE COLOPLAST #28810


name: Provision of medication adherence device


name: Promotion of adherence to medication using adherence packaging


name: Provision of medication tier exception information


name: Assistance with application for renewal of benefits enrollment


name: Enrollment in disease management program


name: Education about medication tier exception process


name: Referral for respiratory disease care management


name: Referral for cardiovascular care management


name: Referral for medication compliance management


name: Referral for obese class III care management


name: Severe acute respiratory syndrome coronavirus 2 vaccination status


name: Osteopathic manipulation using percussion vibration method


name: Date screening for occult blood in feces completed


name: LEA SYMBOLS distance visual acuity chart


name: Visual acuity test using LEA SYMBOLS distance visual acuity chart


name: Date of stool DNA-based colorectal cancer screening


name: Assessment using obesity risk assessment tool


name: Air conducted vestibular evoked myogenic potential test


name: Bone conduction vibration vestibular evoked myogenic potential test


name: Dissection and segmentation of fissure of sylvius


name: Assistance with application for volunteer driver program


name: Assistance with application for rideshare program


name: Assistance with application for public transportation voucher program


name: Assistance with application for paratransit program


name: Assistance with application for microtransit program


name: Assistance with application for Medicaid transportation program


name: Assistance with application for car share program


name: Education about volunteer driver program


name: Education about public transportation voucher program


name: Education about non-emergency medical transportation program


name: Counseling for readiness to achieve transportation security


name: Counseling for barriers to achieve transportation security


name: Counseling for readiness for engagement in transportation insecurity care plan


name: Counseling for barriers to engagement in transportation insecurity care plan


name: Assessment of progress toward goals to achieve transportation security


name: Assessment of goals to achieve transportation security


name: Assessment of barriers in transportation insecurity care plan


name: Assessment for transportation insecurity


name: Evaluation of eligibility for rideshare program


name: Evaluation of eligibility for volunteer driver program


name: Provision of public transportation voucher


name: Evaluation of eligibility for public transportation voucher program


name: Evaluation of eligibility for paratransit program


name: Evaluation of eligibility for microtransit program


name: Evaluation of eligibility for car share program


name: Evaluation of eligibility for vehicle repair program


name: Evaluation of eligibility for non-emergency medical transportation program


name: Evaluation of eligibility for bicycle share program


name: Robot assisted transplant surgery service


name: Neonatal otolaryngology laser surgery service


name: Neurosurgery for psychiatric disorders service


name: Robot assisted colorectal surgery service


name: Robot assisted otolaryngology surgery service


name: Robot assisted gynecological surgery service


name: Robot assisted cardiovascular surgery service


name: Injection of tissue bulking agent into submucosa of anal canal


name: Ultrasensitive ultrasonography of microvasculature


name: Oral and maxillofacial laser surgery service


name: Personality disorder screening questionnaire


name: Childhood trauma questionnaire short form


name: Referral to family-to-family support program


name: Referral to Temporary Assistance for Needy Families Program


name: Referral to National Domestic Violence Hotline


name: Referral to National Elder Fraud Hotline


name: Referral to Low Income Home Energy Assistance Program


name: Referral to Health Insurance Navigator program


name: Referral to general educational development program


name: Referral to English as a second language program


name: Referral to Children's Health Insurance Program


name: Referral to child care financial assistance program


name: Referral to Department of Veterans Affairs Veteran Services officer


name: Referral to Department of Veterans Affairs suicide prevention program


name: Referral to Department of Veterans Affairs Veterans Crisis Line


name: Referral to Department of Veterans Affairs social work program


name: Referral to Department of Veterans Affairs facilities locator


name: Referral to Department of Veterans Affairs mental health services


name: Cornell medical index-health questionnaire


name: Evacuated blood collection tube with lithium heparin


name: Evacuated blood collection tube with sodium citrate


name: Evacuated blood collection tube with spray-dried dipotassium ethylene diamine tetraacetic acid


name: Evacuated blood collection tube with tripotassium ethylene diamine tetraacetic acid


name: Evacuated blood collection tube with sodium ethylenediaminetetraacetic acid/sodium fluoride


name: Evacuated blood collection tube with potassium oxalate/sodium fluoride


name: Evacuated blood collection tube with spray-dried dipotassium ethylene diamine tetraacetic acid for trace element testing


name: Evacuated blood collection tube with silicone-coated interior and silica clot activator and gel separator


name: Evacuated blood collection tube with dipotassium ethylene diamine tetraacetic acid, metal-free


name: Evacuated blood collection tube with heparin sodium, metal-free


name: Deprecated Activated partial thrombplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma


name: Deprecated Activated partial thrombplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma


name: Deprecated Firebush IgE Ab [Units/volume] in Serum


name: Deprecated Burning bush IgE Ab [Units/volume] in Serum


name: Laryngoplasty for laryngeal web, two stage, with keel insertion and removal


name: Electroencephalogram awake and asleep with hyperventilation and/or photic stimulation


name: Measles, mumps, and rubella vaccine (procedure)


name: Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)


name: Japanese encephalitis vaccine (procedure)


name: Measles, mumps, rubella, and varicella vaccine


name: Haemophilus influenzae type b vaccine, PRP-T conjugate (procedure)


name: Deprecated Alternaria alternata IgG Ab [Units/volume] in Serum


name: Deprecated ALTERNARIA ALTERNATA+ALTERNARIA TENUIS IgG Ab [Units/volume] in Serum


name: Deprecated Does your health now limit you in getting in and out of the bathtub [PROMIS]


name: Influenza vaccine, quadrivalent (procedure)


name: Hepatitis A and hepatitis B vaccine (procedure)


name: Guidelines for Selecting Level of Service Based on Medical Decision Making


name: Amount and/or Complexity of Data to Be Reviewed and Analyzed


name: Risk of Complications and/or Morbidity or Mortality of Patient Management


name: Guidelines for Selecting Level of Service Based on Time


name: Hospital Inpatient and Observation Care Services


name: Initial Hospital Inpatient or Observation Care


name: Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and low level of medical decision making, If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and examination and low level of medical decision making. If using time, at least 40 minutes total time on encounter date


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and examination and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and low level of medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and examination and low level of medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and examination and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and straightforward medical decision making. If using time, at least 40 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and history and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and history and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and moderate level of medical decision making. If using time, at least 55 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and high level of medical decision making. If using time, at least 75 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and history and high level of medical decision making. If using time, at least 75 minutes total time on encounter date must be met.


name: Initial hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and high levelof medical decision making. If using time, at least 75 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and high level of medical decision making. If using time, at least 75 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and history and high level of medical decision making. If using time, at least 75 minutes total time on encounter date must be met.


name: Initial hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and high level of medical decision making. If using total time, at least 75 minutes total time on encounter date must be met.


name: Subsequent Hospital Inpatient or Observation Care


name: Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and low level of medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and examination and low level of medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and examination and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and low level of medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and examination and low level of medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and examination and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and straightforward medical decision making. If using time, at least 25 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and history and moderate level of medical decision making. If using time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and moderate level of medical decision making. If using time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate history and moderate level of medical decision making. If using time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and history and moderate level of medical decision making. If using time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate examination and moderate level of medical decision making. If usng time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital observation care, per day, for evaluation and management of patient requiring medically appropriate history and moderate level of medical decision making. If using time, at least 35 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and high level of medical decision making. If using time, at least 50 minutes total time on encounter date must be met.


name: Subsequent hospital inpatient care, per day, for evaluation and management of patient requiring medically appropriate examination and history and high level of medical decision making. If using time, at least 50 minutes total time on encounter date must be met.